VNS Health And Vitalic Release Early Findings From a Telehealth-Based Behavioral Health Program Targeting High-Risk ...

LYON, France--(BUSINESS WIRE)--Regulatory News: PHAXIAM Therapeutics (Euronext: PHXM - FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial ...

Additional data presented further reinforces the favorable and consistent safety and efficiency profile of the VARIPULSE platform ii,iii,iv,v Additional VARIPULSE Platform data presented at AF ...

A new pilot study known as STAMINA (Senolytics To Alleviate Mobility Issues and Neurological Impairments in Aging), that focused on the effects of senolytic medications, Dasatinib and Quercetin (DQ), ...

Neola Medical announces completion of patient enrollment in its clinical pilot study on preterm born babies in Sweden. All ten babies have now been included in the study, marking an important mileston ...

New research from the Institute for the Science of Early Years at the University of East London, supported by Kinder, is exploring how shared play between parents and young children shapes ...

A pilot randomized trial of older adults with mild cognitive impairment given either daily low-dose lithium carbonate or placebo for 2 years met its feasibility target, according to results published ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful ...

NEW DELHI- The Delhi government has signed a Memorandum of Understanding (MoU) with the Indian Institute of Technology Madras (IIT Madras) to launch a pilot study on photocatalytic “smog-eating” ...